期刊文献+

联合检测血清淀粉样蛋白A、细胞角蛋白19片段、糖链抗原125、糖链抗原153对乳腺癌的临床诊断价值 被引量:7

Clinical value of the combined detection of SAA,CYFRA21-1,CA125 and CA153 in the diagnosis of breast cancer
原文传递
导出
摘要 目的探讨联合检测血清淀粉样蛋白A(SAA)、细胞角蛋白19片段(CYFRA21-1)、CA125、CA153在乳腺癌诊断中的意义。方法收集185例乳腺癌患者为乳腺癌组,乳腺良性肿瘤者和健康体检者各50例作为良性组和对照组,检测各组的SAA、CYFRA21-1、CA125和CA153值。使用SPSS 17. 0软件,经Mann-Whitney U检验比较各组间血清SAA、CYFRA21-1、CA125、CA153水平是否存在显著差异,运用逐步Logitic回归并绘制SAA、CYFRA21-1、CA125、CA153以及联合检测的ROC受试者工作曲线,比较各指标对乳腺癌诊断效能。结果乳腺癌组的SAA、CYFRA21-1、CA125和CA153水平高于良性组和对照组(P <0. 05),良性组和对照组之间差异无统计学意义(P> 0. 05);SAA、CYFRA21-1、CA125和CA153的ROC曲线下面积(AUC)分别为0. 758、0. 789、0. 794和0. 799,联合检测AUC为0. 897,诊断效能明显提高,优于单项检测。结论在乳腺癌诊断中,联合检测SAA、CYFRA21-1、CA125和CA153可以提高检测的准确度、灵敏度,是诊断乳腺癌的较佳选择。 Objective To investigate the significance of combined detection of serum SAA,CYFRA21-1,CA125,CA153 in the diagnosis of breast cancer. Methods A total of 185 breast cancer patients were enrolled in the breast cancer group,50 patients with benign breast tumors and 50 healthy subjects were enrolled in the benign group and the control group. The values of SAA,CYFRA21-1,CA125 and CA153 were also detected. Using the SPSS 17. 0 software,the Mann-Whitney U test was used to compare the differences of serum SAA,CYFRA21-1,CA125,CA153 levels among the groups;the stepwise Logistic regression was used to draw ROC curves for SAA,CYFRA21-1,CA125,CA153,and their combined test,so as to compare the efficacy of each indicator for breast cancer diagnosis. Results The levels of SAA,CYFRA21-1,CA125 and CA153 in breast cancer group were higher than those in benign group and control group( P < 0. 05). There was no significant difference between benign group and control group( P > 0. 05);the area under the ROC curve( AUC) of SAA,CYFRA21-1,CA125 and CA153 were 0. 758,0. 789,0. 794 and 0. 799,respectively. The combined detection of AUC was 0. 897,and the diagnostic efficiency was significantly improved,which was superior to the single test. Conclusion In the diagnosis of breast cancer,combined detection of SAA,CYFRA21-1,CA125 and CA153 can improve the accuracy and sensitivity of detection,and is a better choice for the diagnosis of breast cancer.
作者 杨利萍 李登云 朱庆文 陈芳建 YANG Li-ping;LI Deng-yun;ZHU Qing-wen;CHEN Fang-jian(Clinical hiboratory,Quzhou People's Hospital Affiliated to Zhejiang University oj Traditional Chinese Medicine,Quzhou,Zhejiang 324000,China)
出处 《中国卫生检验杂志》 CAS 2019年第24期3024-3026,3029,共4页 Chinese Journal of Health Laboratory Technology
关键词 血清淀粉样蛋白A 细胞角蛋白19 糖链抗原125 糖链抗原153 乳腺癌 Serum amyloid A Cytokeratin 19 Carbohydrate antigen 125 Carbohydrate 153 Breast cancer
  • 相关文献

参考文献13

二级参考文献98

  • 1胡惠芳,杨永青.156例乳腺癌术后动态检测血清CA15-3和CEA的临床分析[J].放射免疫学杂志,2005,18(5):351-353. 被引量:9
  • 2DAN-HUI LIU,XIAO-MIN WANG,LI-JUAN ZHANG,SONG-WEI DAI,LI-YUN LIU,JI-FU LIU,SHAN-SHAN WU,SHUAN-YING YANG,SAM FU,XUE-YUAN XIAO,DA-CHENG HE.Serum Amyloid A Protein: A Potential Biomarker Correlated With Clinical Stage of Lung Cancer[J].Biomedical and Environmental Sciences,2007,20(1):33-40. 被引量:12
  • 3戴嵩玮,王小敏,刘丽云,刘吉福,武珊珊,黄凌云,肖雪媛,何大澄.一个在肺癌血清中高表达的标志分子SAA的发现及鉴定[J].中国科学(C辑),2007,37(2):129-134. 被引量:25
  • 4全国肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究(1990-1992)[M].北京:人民卫生出版社,2008.82-101.
  • 5Taylor B A, Rowe L. Genes for serum amyloid A proteins map to Chromosome7 in the mouse[J]. Mol Gen Genet, 1984,195 (3):491-499.
  • 6Malle E,Sodin Semrl S, Kovacevic A. Serum amyloid A: an acute-phase protein involved in tumour pathogenesis[J]. Cell Mol Life Sci, 2009,66(1) :9- 26.
  • 7Hiratsuka S, Watanabe A, Sakurai Y, et al. The S100AS-serum amyloid A3-TLR4 paracrine cascade establishes a pre-meta static phase [J]. Nat Cell Biol, 2008,10(11) :1349-1355.
  • 8Cho W, Yip T, Yip C, et al. Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling [J]. Clin Cancer Res, 2004,10(1):43 -52.
  • 9Engwegen J Y, Mehra N, Haanen J B, et al. Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in newpopulations[J]. Lab Invest, 2007,87(2): 161-172.
  • 10Moshkovskii S A, Serebryakova M V, Kuteykin-Teplyakov K B, et al. Ovarian cancer marker of 11. 7 kDa detected by proteomics is a serum amyloid A1 [J]. Proteomics, 2005,5 (14): 3790-3797.

共引文献989

同被引文献102

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部